Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The integration of BRCA testing into oncology clinics.

British journal of nursing (Mark Allen Publishing) - 23 Jun 2016

Percival Natalie, George Angela, Gyertson Jennifer, Hamill Monica, Fernandes Andreia, Davies Emily, Rahman Nazneen, Banerjee Susana

Abstract excerpt

PURPOSE: The PARP inhibitor, Olaparib, is approved for women with BRCA-mutated ovarian cancer. Therefore there is an urgent need to test patients and obtain results in time to influence treatment. Models of BRCA testing, such as the mainstreaming oncogenetic pathway, involving oncology health professionals are being used. The authors report on the establishment of the extended role of the clinical nurse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Phthalazines
Share to Piperazines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Informed Consent

Share to Nurse's Role

Share to Patient Satisfaction

Share to Poly(ADP-ribose) Polymerase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 27345073
DOI: 10.12968/bjon.2016.25.12.690
PMCID: PMC5993185

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The integration of BRCA testing into oncology clinics.PMID 27345073Read ↗

Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancerSemantic proximity Read ↗

Oncologist-led BRCA ‘mainstreaming’ in the ovarian cancer clinic: A study of 255 patients and its impact on their managementSemantic proximity Read ↗

Mainstreamed genetic testing for women with ovarian cancer: first-year experience.Semantic proximity Read ↗

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.Semantic proximity Read ↗

Models of Best Practice: Nurse Integration Into the BRCA1/BRCA2 Testing Pathway.Semantic proximity Read ↗

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.Semantic proximity Read ↗

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsSemantic proximity Read ↗

Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.Semantic proximity Read ↗

An Australian mainstream genetic testing program: Clinicians views about current and future practicesSemantic proximity Read ↗

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomesSemantic proximity Read ↗

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of EnglandSemantic proximity Read ↗

Mainstream consent programs for genetic counseling in cancer patients: A systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.